Living kidney transplantation: A starting experience

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 475-478

  Veroux, P ^a   Veroux, M ^a   Puliatti, C ^a   Macarone, M ^a   Cappello, D ^a   Caglia P ^a   Puliatti, D ^a   Vizcarra, D ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE PANCREATITIS; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; EXPERIENCE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MORBIDITY; NEPHROTOXICITY; NEUROTOXICITY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; WOUND INFECTION;

AGED; FEMALE; HUMANS; IMMUNOSUPPRESSION; ITALY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; RETROSPECTIVE STUDIES; SPOUSES;

EID: 2042496260     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.02.005     Document Type: Conference Paper

References (11)

1. Matas A.J., Payne W.D., Sutherland D.E.R., et al. 2, 500 living donor kidney transplants a single-center experience. Ann Surg. 234:2001;149
2. Veroux P., Veroux M., Puliatti C., et al. Living transplantation using a kidney with a large cyst as curative treatment of donor's hypertension. Nephrol Dial Transplant. 17:2002;2258
3. Veroux P., Veroux M., Puliatti C., et al. Tacrolimus-induced neurotoxicity in kidney transplant recipients. Transplant Proc. 34:2002;3188
4. Ellison M.D., McBride M.A., Taranto S.E., et al. Living kidney donors in need of kidney transplants a report from the organ procurement and transplantation network. Transplantation. 74:2002;1349
5. Saran R., Marshall S.M., Madsen R., et al. Long-term follow-up of kidney donors a longitudinal study. Nephrol Dial Transplant. 12:1997;1615
6. Karakayali H., Moray G., Demirag A., et al. Long-term follow-up of 102 living kidney donors. Transplant Proc. 30:1998;721
7. Isotani S., Fujisawa M., Ichikawa Y., et al. Quality of life of living kidney donors the short-form 36-item health questionnaire survey. Urology. 60:2002;588
8. Margreiter R. European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation a randomised multicentre study. Lancet. 359:2002;741
9. Jensik S.C. FK 506 Kidney Transplant Study Group. Tacrolimus (FK 506) in kidney transplantation three-year survival results of the US multicenter, randomised, comparative trial. Transplant Proc. 30:1998;1216
10. Kobashigawa J.A., Kasiske B.L. Hyperlipidemia in solid organ transplantation. Transplantation. 63:1997;331
11. Dimény E., Wahlberg J., Lithell H., et al. Hyperlipidaemia in renal transplantation risk factor for long-term outcome. Eur J Clin Invest. 25:1995;574